Pharmadrug Stock Analysis

LMLLF Stock  USD 0.01  0  62.67%   
Pharmadrug is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Pharmadrug pink sheet analysis is to determine its intrinsic value, which is an estimate of what Pharmadrug is worth, separate from its market price. There are two main types of Pharmadrug's stock analysis: fundamental analysis and technical analysis.
The Pharmadrug pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pharmadrug's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pharmadrug. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Pharmadrug Pink Sheet Analysis Notes

The company has price-to-book ratio of 0.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharmadrug recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 2nd of August 2016. Pharmadrug Inc. operates as a specialty pharmaceutical company. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Pharmadrug is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pharmadrug contact Daniel Cohen at 647 202 1824 or learn more at https://www.pharmadrug.ca.

Pharmadrug Investment Alerts

Pharmadrug is way too risky over 90 days horizon
Pharmadrug has some characteristics of a very speculative penny stock
Pharmadrug appears to be risky and price may revert if volatility continues
The company reported the revenue of 494.99 K. Net Loss for the year was (5.63 M) with profit before overhead, payroll, taxes, and interest of 182.04 K.
Pharmadrug has accumulated about 126.38 K in cash with (4.13 M) of positive cash flow from operations.

Pharmadrug Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharmadrug's market, we take the total number of its shares issued and multiply it by Pharmadrug's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 2nd of December, Pharmadrug holds the Risk Adjusted Performance of 0.0275, semi deviation of 13.89, and Coefficient Of Variation of 4255.86. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmadrug, as well as the relationship between them. Please check Pharmadrug coefficient of variation and the relationship between the jensen alpha and skewness to decide if Pharmadrug is priced some-what accurately, providing market reflects its current price of 0.0122 per share. As Pharmadrug appears to be a penny stock we also advise to check out its total risk alpha numbers.

Pharmadrug Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pharmadrug middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pharmadrug. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Pharmadrug Predictive Daily Indicators

Pharmadrug intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pharmadrug pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pharmadrug Forecast Models

Pharmadrug's time-series forecasting models are one of many Pharmadrug's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharmadrug's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Pharmadrug Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Pharmadrug prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharmadrug shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Pharmadrug. By using and applying Pharmadrug Pink Sheet analysis, traders can create a robust methodology for identifying Pharmadrug entry and exit points for their positions.
Pharmadrug Inc. operates as a specialty pharmaceutical company. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Pharmadrug to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Complementary Tools for Pharmadrug Pink Sheet analysis

When running Pharmadrug's price analysis, check to measure Pharmadrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmadrug is operating at the current time. Most of Pharmadrug's value examination focuses on studying past and present price action to predict the probability of Pharmadrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmadrug's price. Additionally, you may evaluate how the addition of Pharmadrug to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas